Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Qiming's Portfolio Company InventisBio Lists on STAR Market 2022-07-25 11:55
Qiming's Portfolio Company InventisBio Lists on STAR Market 2022-07-25 11:55
Qiming Venture Partners Announces Closing of Funds Totaling US$3.2 Billion 2022-07-11 09:00
Qiming's Nisa Leung, Duane Kuang Named on 2022 Forbes Midas List 2022-04-13 09:20
Gan & Lee Pharmaceuticals Begins First-In-Human Trial in U.S. for Investigational Drug, GZR18 2022-03-11 03:35
Qiming Venture Partners Announces Annual Promotions 2022-01-07 16:12
Gan & Lee Pharmaceuticals Announces U.S. FDA Clearance of Investigational New Drug (IND) Application for a Novel Glucagon-Like Peptide-1 Analogue, GZR18 2021-12-07 05:54
Gan & Lee Pharmaceuticals Concludes Phase 3 Studies of Gan & Lee Insulin Glargine (GL-GLA) 2021-10-14 20:46
Gan & Lee Pharmaceuticals to present data at the 57th Annual European Association for the Study of Diabetes Meeting 2021-09-09 15:00
New Data on Phase 1 Proposed Biosimilar Gan & Lee Insulins Aspart (GL-ASP), Lispro (GL-LIS), and Glargine (GL-GLA) Presented at the American Diabetes Association's 81st Scientific Sessions 2021-07-02 15:00
Gan & Lee receives EMA orphan drug designation for Phase I drug candidate GLR2007 for the treatment of glioma 2021-04-06 20:53
Gan & Lee Announces New Partnership with International Diabetes Federation 2021-02-22 17:00
Phase 1 Drug Candidate GLR2007 Developed by Gan & Lee has been Granted Fast Track Designation by the U.S. FDA 2021-01-29 22:53
Qiming's Portfolio Company Gan & Lee Pharmaceuticals Lands A-Shares Main Board 2020-06-29 11:31
1